Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Joyce Lee

Concepts (354)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Diseases, Interstitial
67
2026
677
12.830
Why?
Idiopathic Pulmonary Fibrosis
63
2026
697
11.170
Why?
Arthritis, Rheumatoid
26
2026
1184
4.800
Why?
Scleroderma, Systemic
10
2025
123
2.400
Why?
Immunosuppressive Agents
9
2025
824
2.030
Why?
Connective Tissue Diseases
9
2021
85
1.680
Why?
Cryptogenic Organizing Pneumonia
2
2025
20
1.620
Why?
Lung
28
2025
4119
1.620
Why?
Mucin-5B
5
2025
234
1.520
Why?
Vital Capacity
19
2025
293
1.500
Why?
Tomography, X-Ray Computed
28
2025
2766
1.460
Why?
Autoimmune Diseases
11
2025
466
1.460
Why?
Adrenal Cortex Hormones
4
2025
483
1.360
Why?
Disease Progression
14
2025
2857
1.350
Why?
Gastroesophageal Reflux
5
2020
232
1.230
Why?
Rheumatic Diseases
5
2024
101
1.170
Why?
Pulmonary Fibrosis
10
2025
395
1.140
Why?
Prognosis
24
2025
4331
1.120
Why?
Humans
136
2026
145625
1.010
Why?
Myositis
5
2025
57
0.980
Why?
Alveolitis, Extrinsic Allergic
6
2022
96
0.950
Why?
Respiratory Aspiration
4
2020
32
0.910
Why?
Biomarkers
12
2025
4329
0.880
Why?
Telomere
3
2025
300
0.850
Why?
Aged
54
2026
26251
0.840
Why?
Middle Aged
58
2026
36359
0.840
Why?
Idiopathic Interstitial Pneumonias
4
2019
44
0.830
Why?
Quality of Life
4
2024
3187
0.800
Why?
Diagnosis, Differential
10
2025
1500
0.760
Why?
Telomerase
2
2023
252
0.740
Why?
Carcinoma, Hepatocellular
5
2025
369
0.740
Why?
Pulmonary Surfactants
1
2023
105
0.730
Why?
Histamine H2 Antagonists
2
2013
22
0.720
Why?
Glucocorticoids
3
2024
536
0.710
Why?
Matrix Metalloproteinase 7
1
2021
25
0.700
Why?
Proton Pump Inhibitors
2
2013
101
0.680
Why?
Respiratory Function Tests
11
2025
543
0.680
Why?
Male
71
2026
73014
0.670
Why?
Proteomics
3
2025
1202
0.640
Why?
Rheumatology
5
2024
136
0.630
Why?
Lung Transplantation
10
2025
326
0.620
Why?
Female
70
2026
79080
0.610
Why?
Cellular Senescence
1
2021
225
0.560
Why?
Telomere Shortening
3
2025
20
0.540
Why?
Liver Neoplasms
5
2025
774
0.530
Why?
Genetic Predisposition to Disease
3
2026
2455
0.520
Why?
Prospective Studies
13
2025
8087
0.510
Why?
Severity of Illness Index
10
2025
2910
0.490
Why?
Abatacept
3
2025
56
0.490
Why?
Dyspnea
5
2023
251
0.470
Why?
Patient Satisfaction
2
2021
698
0.470
Why?
Forecasting
1
2017
386
0.460
Why?
Survival Rate
11
2025
2078
0.460
Why?
Risk Assessment
10
2021
3678
0.450
Why?
Longitudinal Studies
8
2017
3005
0.400
Why?
Cohort Studies
13
2025
6045
0.400
Why?
Patient Education as Topic
2
2016
769
0.390
Why?
Azathioprine
2
2024
43
0.390
Why?
Pulmonary Diffusing Capacity
5
2020
78
0.380
Why?
Early Diagnosis
2
2025
249
0.370
Why?
Precision Medicine
1
2017
462
0.370
Why?
Rituximab
2
2024
208
0.360
Why?
Hypertension, Pulmonary
3
2022
1957
0.360
Why?
Pepsin A
1
2011
18
0.350
Why?
Antirheumatic Agents
4
2024
309
0.340
Why?
Comprehensive Health Care
1
2011
24
0.340
Why?
Fundoplication
1
2011
49
0.330
Why?
Sleep Apnea, Obstructive
1
2015
300
0.330
Why?
Carbon Monoxide
4
2019
82
0.310
Why?
Veterans
4
2023
1647
0.310
Why?
Endotoxins
1
2010
215
0.300
Why?
Bronchoalveolar Lavage Fluid
2
2011
641
0.300
Why?
Forced Expiratory Volume
4
2025
451
0.300
Why?
Sirolimus
1
2011
282
0.300
Why?
Proportional Hazards Models
7
2024
1318
0.290
Why?
Phenotype
6
2025
3186
0.290
Why?
Anti-Bacterial Agents
1
2019
1935
0.280
Why?
Walk Test
2
2025
82
0.270
Why?
United States
17
2025
16041
0.270
Why?
Biopsy
5
2025
1073
0.270
Why?
Risk Factors
12
2026
10840
0.270
Why?
Retrospective Studies
16
2024
17291
0.260
Why?
Emphysema
2
2022
100
0.260
Why?
Mycophenolic Acid
3
2024
117
0.260
Why?
Acute Lung Injury
1
2010
311
0.250
Why?
Lung Diseases
3
2020
787
0.250
Why?
Comorbidity
5
2015
1652
0.250
Why?
Autoantibodies
2
2015
1498
0.230
Why?
Prevalence
5
2022
2852
0.230
Why?
Cancer-Associated Fibroblasts
1
2025
23
0.230
Why?
Immunotherapy
3
2025
669
0.230
Why?
Depression
1
2015
1566
0.230
Why?
Predictive Value of Tests
4
2017
2097
0.220
Why?
Thoracic Surgery, Video-Assisted
1
2025
55
0.220
Why?
Pulmonologists
1
2025
14
0.220
Why?
Yttrium Radioisotopes
2
2023
64
0.220
Why?
Mutation
3
2023
4082
0.220
Why?
Pyridones
2
2024
210
0.220
Why?
Antineoplastic Agents, Phytogenic
1
2026
178
0.220
Why?
Paclitaxel
1
2026
258
0.220
Why?
Sex Factors
4
2020
2101
0.210
Why?
Aged, 80 and over
10
2024
8351
0.210
Why?
Case-Control Studies
6
2021
3633
0.200
Why?
Endothelium, Vascular
1
2010
952
0.200
Why?
Spirometry
3
2025
234
0.200
Why?
Biopsy, Needle
3
2019
182
0.200
Why?
Chronic Disease
6
2020
1824
0.200
Why?
Pulmonary Emphysema
2
2025
276
0.190
Why?
Exercise Tolerance
1
2025
288
0.190
Why?
Sputum
1
2025
302
0.190
Why?
Blood Proteins
1
2025
239
0.190
Why?
Urinary Bladder Neoplasms
1
2026
257
0.190
Why?
Fatty Liver
1
2025
251
0.190
Why?
Treatment Outcome
8
2025
11744
0.190
Why?
Polychlorinated Dibenzodioxins
1
2022
10
0.190
Why?
Transforming Growth Factor beta
1
2025
466
0.180
Why?
Fibrosis
3
2022
568
0.180
Why?
T-Lymphocytes, Regulatory
1
2025
411
0.180
Why?
Indoles
2
2024
509
0.180
Why?
Recurrence
1
2025
1125
0.180
Why?
Genotype
2
2025
1866
0.180
Why?
Adult
19
2025
40821
0.170
Why?
Genetic Testing
1
2025
491
0.170
Why?
Self Care
2
2017
396
0.170
Why?
Monocytes
2
2021
538
0.170
Why?
Organizational Objectives
1
2021
67
0.170
Why?
Incidence
5
2023
2910
0.170
Why?
Nursing Research
1
2021
49
0.160
Why?
Genetic Markers
1
2022
337
0.160
Why?
Societies, Medical
5
2025
901
0.160
Why?
Chemoembolization, Therapeutic
1
2021
88
0.160
Why?
Kaplan-Meier Estimate
5
2017
959
0.160
Why?
Smoking
3
2024
1478
0.160
Why?
Patient Outcome Assessment
1
2021
128
0.160
Why?
Chemokine CX3CL1
1
2020
25
0.150
Why?
Immunohistochemistry
3
2019
1709
0.150
Why?
Disease Models, Animal
1
2010
4565
0.150
Why?
Survival Analysis
3
2012
1372
0.150
Why?
Models, Organizational
1
2020
145
0.150
Why?
Disease Management
4
2018
649
0.150
Why?
Myositis, Inclusion Body
1
2019
11
0.150
Why?
Graft Rejection
2
2020
504
0.150
Why?
Radiography
2
2011
856
0.140
Why?
Wnt-5a Protein
1
2018
25
0.140
Why?
Gain of Function Mutation
1
2018
35
0.140
Why?
Body Weight
1
2022
964
0.140
Why?
Immunity, Innate
1
2024
843
0.140
Why?
Ambulatory Care Facilities
1
2020
267
0.130
Why?
Hypoxia
1
2025
1209
0.130
Why?
Signal Transduction
2
2023
5234
0.130
Why?
Focus Groups
2
2020
587
0.130
Why?
Randomized Controlled Trials as Topic
1
2024
1754
0.130
Why?
International Cooperation
1
2017
192
0.120
Why?
Myofibroblasts
1
2018
149
0.120
Why?
Weight Loss
1
2022
857
0.120
Why?
Amino Acyl-tRNA Synthetases
1
2016
32
0.120
Why?
Health Status Indicators
1
2017
166
0.120
Why?
Women's Health
1
2018
317
0.120
Why?
Patient-Centered Care
1
2021
551
0.120
Why?
Extracellular Vesicles
1
2018
175
0.120
Why?
Tomography Scanners, X-Ray Computed
1
2015
21
0.110
Why?
Practice Patterns, Physicians'
1
2025
1370
0.110
Why?
Acute Disease
3
2016
1033
0.110
Why?
Follow-Up Studies
4
2019
5397
0.110
Why?
Sarcoidosis
1
2017
164
0.110
Why?
Cause of Death
1
2017
455
0.110
Why?
Pulmonary Medicine
1
2015
78
0.110
Why?
Antibiotic Prophylaxis
1
2016
133
0.110
Why?
Sleep Wake Disorders
1
2018
314
0.100
Why?
Nails
1
2014
14
0.100
Why?
Hyperpigmentation
1
2014
26
0.100
Why?
Hospitalization
1
2025
2468
0.100
Why?
Bronchodilator Agents
1
2015
186
0.100
Why?
Body Mass Index
1
2022
2446
0.100
Why?
Laparoscopy
1
2018
474
0.100
Why?
Oxygen Inhalation Therapy
1
2016
189
0.100
Why?
Gene Expression Profiling
1
2020
1790
0.100
Why?
Arsenic
1
2014
66
0.100
Why?
Interleukin-13
1
2014
149
0.100
Why?
Age Factors
3
2019
3321
0.100
Why?
Diagnostic Imaging
1
2016
340
0.100
Why?
Keratin-18
1
2012
12
0.090
Why?
Counseling
1
2016
403
0.090
Why?
Cystic Fibrosis
1
2023
1164
0.090
Why?
Autoimmunity
2
2015
924
0.090
Why?
Maternal Exposure
1
2014
189
0.090
Why?
Mass Screening
3
2026
1300
0.090
Why?
Microspheres
2
2023
142
0.090
Why?
Interviews as Topic
1
2016
926
0.090
Why?
Sjogren's Syndrome
2
2024
31
0.090
Why?
Fatigue
1
2014
362
0.090
Why?
Age Distribution
3
2019
395
0.090
Why?
Time Factors
2
2024
7079
0.080
Why?
Dermatitis, Atopic
1
2014
319
0.080
Why?
Algorithms
2
2016
1843
0.080
Why?
Everolimus
1
2011
112
0.080
Why?
Epithelial Cells
2
2014
1118
0.080
Why?
Programmed Cell Death 1 Receptor
2
2023
268
0.080
Why?
Sodium-Potassium-Exchanging ATPase
1
2010
55
0.080
Why?
Tumor Microenvironment
2
2025
745
0.080
Why?
Animals
7
2025
38030
0.080
Why?
Goals
1
2011
187
0.080
Why?
Fetus
1
2014
798
0.070
Why?
Delphi Technique
2
2022
347
0.070
Why?
Leukocytes
2
2025
301
0.070
Why?
Alveolar Epithelial Cells
1
2010
121
0.070
Why?
Health Status
1
2014
822
0.070
Why?
Singapore
2
2021
27
0.070
Why?
Sensitivity and Specificity
1
2013
1992
0.070
Why?
Virus Diseases
1
2011
219
0.070
Why?
Qualitative Research
1
2016
1720
0.070
Why?
Syndrome
2
2022
377
0.070
Why?
Models, Statistical
1
2012
667
0.070
Why?
Proto-Oncogene Proteins c-akt
1
2010
438
0.070
Why?
DNA
1
2014
1418
0.060
Why?
Multivariate Analysis
2
2025
1531
0.060
Why?
Pulmonary Alveoli
2
2025
385
0.060
Why?
Antibodies, Monoclonal
1
2014
1511
0.060
Why?
Micelles
1
2026
37
0.060
Why?
Cell Membrane
1
2010
701
0.060
Why?
Internationality
2
2017
156
0.060
Why?
Japan
1
2026
149
0.060
Why?
France
1
2025
40
0.060
Why?
Pulmonary Surfactant-Associated Protein D
1
2025
31
0.060
Why?
Promoter Regions, Genetic
2
2021
1236
0.060
Why?
Logistic Models
2
2025
2112
0.050
Why?
Methotrexate
2
2021
234
0.050
Why?
Genetic Loci
1
2026
272
0.050
Why?
Cyclophosphamide
1
2025
275
0.050
Why?
Mixed Connective Tissue Disease
1
2024
10
0.050
Why?
Pandemics
2
2024
1700
0.050
Why?
Prednisone
2
2019
229
0.050
Why?
Sex Distribution
2
2015
379
0.050
Why?
Mice
3
2025
18266
0.050
Why?
Demography
1
2024
274
0.050
Why?
Professional Practice Gaps
1
2023
15
0.050
Why?
Chromosome Deletion
1
2023
126
0.050
Why?
Adaptive Immunity
1
2024
172
0.050
Why?
CD3 Complex
1
2023
112
0.050
Why?
Agent Orange
1
2022
3
0.050
Why?
2,4,5-Trichlorophenoxyacetic Acid
1
2022
3
0.050
Why?
2,4-Dichlorophenoxyacetic Acid
1
2022
14
0.050
Why?
Palliative Care
1
2011
1032
0.050
Why?
CTLA-4 Antigen
1
2023
105
0.050
Why?
Antibody Formation
1
2024
290
0.050
Why?
Whole Genome Sequencing
1
2023
183
0.040
Why?
Respiratory Mucosa
1
2025
323
0.040
Why?
Exome
1
2023
232
0.040
Why?
Probability
1
2022
308
0.040
Why?
Patient Reported Outcome Measures
1
2025
502
0.040
Why?
Administration, Intravenous
1
2021
172
0.040
Why?
Double-Blind Method
1
2025
2064
0.040
Why?
Evidence-Based Medicine
1
2024
727
0.040
Why?
Family
1
2025
680
0.040
Why?
Bayes Theorem
1
2022
424
0.040
Why?
CX3C Chemokine Receptor 1
1
2020
19
0.040
Why?
Leukocytes, Mononuclear
1
2023
585
0.040
Why?
Total Lung Capacity
1
2019
29
0.040
Why?
Pilot Projects
1
2025
1878
0.040
Why?
Immunologic Factors
1
2022
244
0.040
Why?
Allografts
1
2020
148
0.040
Why?
Drug Discovery
1
2020
153
0.040
Why?
Antibodies, Viral
1
2024
683
0.040
Why?
Safety
1
2021
346
0.040
Why?
Mice, Inbred C57BL
1
2010
6021
0.040
Why?
Cross-Sectional Studies
2
2025
5875
0.040
Why?
Fibroblasts
1
2025
1033
0.040
Why?
Ireland
1
2019
33
0.040
Why?
Genome-Wide Association Study
1
2026
1526
0.040
Why?
Embolization, Therapeutic
1
2021
246
0.040
Why?
Dermatomyositis
1
2019
24
0.040
Why?
Insulin
1
2010
2524
0.040
Why?
Echocardiography
1
2022
645
0.030
Why?
Rare Diseases
1
2019
115
0.030
Why?
Polymorphism, Single Nucleotide
1
2026
2228
0.030
Why?
Combined Modality Therapy
1
2021
1269
0.030
Why?
Hydrogen-Ion Concentration
1
2020
533
0.030
Why?
Intention to Treat Analysis
1
2018
78
0.030
Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2018
103
0.030
Why?
Education
1
2018
102
0.030
Why?
Behavior
1
2018
90
0.030
Why?
Morbidity
1
2018
317
0.030
Why?
United Kingdom
1
2019
376
0.030
Why?
Sleep Apnea Syndromes
1
2018
98
0.030
Why?
CD8-Positive T-Lymphocytes
1
2023
929
0.030
Why?
Medicare
1
2023
907
0.030
Why?
Comprehension
1
2018
175
0.030
Why?
Linear Models
1
2019
847
0.030
Why?
Registries
1
2025
2382
0.030
Why?
Antibodies, Antinuclear
1
2016
60
0.030
Why?
Muscle Strength
1
2019
332
0.030
Why?
Flow Cytometry
1
2020
1160
0.030
Why?
Odds Ratio
1
2018
1070
0.030
Why?
Gene Expression
1
2020
1461
0.030
Why?
California
1
2017
473
0.030
Why?
Evaluation Studies as Topic
1
2015
160
0.030
Why?
Global Health
1
2018
402
0.030
Why?
Monitoring, Physiologic
1
2017
278
0.030
Why?
Pneumonia, Aspiration
1
2015
16
0.030
Why?
Vaccination
1
2024
1444
0.030
Why?
Bronchiolitis Obliterans
1
2015
59
0.030
Why?
Recovery of Function
1
2019
721
0.030
Why?
Regression Analysis
1
2017
994
0.030
Why?
Sampling Studies
1
2014
97
0.030
Why?
San Francisco
1
2014
60
0.030
Why?
Chicago
1
2014
62
0.030
Why?
Europe
1
2015
420
0.030
Why?
Neck
1
2014
107
0.030
Why?
Patient Acuity
1
2013
46
0.020
Why?
Endothelial Cells
1
2020
876
0.020
Why?
Texas
1
2014
279
0.020
Why?
Mice, SCID
1
2014
360
0.020
Why?
Observational Studies as Topic
1
2013
133
0.020
Why?
Enzyme Inhibitors
1
2016
820
0.020
Why?
Protein Kinase Inhibitors
1
2019
982
0.020
Why?
Developing Countries
1
2014
312
0.020
Why?
Surveys and Questionnaires
1
2025
6050
0.020
Why?
Young Adult
2
2022
14240
0.020
Why?
Endoplasmic Reticulum Stress
1
2012
120
0.020
Why?
Torque teno virus
1
2011
1
0.020
Why?
DNA Virus Infections
1
2011
3
0.020
Why?
Up-Regulation
1
2014
840
0.020
Why?
Cells, Cultured
1
2018
4112
0.020
Why?
Academic Medical Centers
1
2014
560
0.020
Why?
Molecular Targeted Therapy
1
2014
446
0.020
Why?
Mass Spectrometry
1
2014
728
0.020
Why?
Pulmonary Disease, Chronic Obstructive
1
2018
926
0.020
Why?
Microarray Analysis
1
2011
117
0.020
Why?
Models, Theoretical
1
2014
558
0.020
Why?
Colorado
1
2020
4588
0.020
Why?
Subcellular Fractions
1
2010
73
0.020
Why?
GTPase-Activating Proteins
1
2010
81
0.020
Why?
Body Fluids
1
2010
70
0.020
Why?
Practice Guidelines as Topic
1
2017
1581
0.020
Why?
rab GTP-Binding Proteins
1
2010
76
0.020
Why?
Adolescent
2
2022
22451
0.020
Why?
Reproducibility of Results
1
2017
3396
0.020
Why?
Oligonucleotide Array Sequence Analysis
1
2011
751
0.020
Why?
Inflammation
1
2020
2915
0.020
Why?
Models, Biological
1
2016
1758
0.020
Why?
Protein Transport
1
2010
439
0.020
Why?
Sequence Analysis, DNA
1
2011
771
0.020
Why?
Polymerase Chain Reaction
1
2011
1030
0.020
Why?
Phosphatidylinositol 3-Kinases
1
2010
384
0.020
Why?
Telemedicine
1
2017
956
0.020
Why?
Cattle
1
2010
938
0.020
Why?
Asthma
1
2018
1800
0.020
Why?
Respiratory Tract Infections
1
2011
399
0.010
Why?
Rats, Sprague-Dawley
1
2010
2533
0.010
Why?
Apoptosis
1
2012
2436
0.010
Why?
Rats
1
2010
5574
0.010
Why?
Pregnancy
1
2014
7217
0.010
Why?
Infant
1
2014
10093
0.010
Why?
Child
1
2014
22638
0.010
Why?
Lee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)